Autologous CAR-T Cell Therapy

· Hebei Senlang Biotechnology Inc., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CAR-T Cell Therapy, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study [EARLY_Phase 1]

See pricing